Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer

Published:2020-11-08 Issue:5 Volume:11 Page:2085-2095
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Date Abhijit A.,Kates Max,Yoshida Takahiro,Babu Taarika,Afzal Umara,Kanvinde Pranjali,Baras Alexander,Anders Nicole,He Ping,Rudek Michelle,Hanes Justin,Bivalacqua Trinity J.,Ensign Laura M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s13346-020-00870-w.pdf

Reference39 articles.

1. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2015;65(1):5–29.

3. Kamat AM, Sylvester RJ, Bohle A, Palou J, Lamm DL, Brausi M, et al. Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the international bladder cancer group. J Clin Oncol. 2016;34(16):1935–44.

4. Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol. 2000;163(4):1124–9.

5. Shelley MD, Wilt TJ, Court J, Coles B, Kynaston H, Mason MD. Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials. BJU Int. 2004;93(4):485–90.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into ocular therapeutics: A comprehensive review of anatomy, barriers, diseases and nanoscale formulations for targeted drug delivery;Journal of Drug Delivery Science and Technology;2024-08

2. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics;International Journal of Pharmaceutics;2024-06

3. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives;Advanced Drug Delivery Reviews;2023-05

4. Induction of the integrated stress response in the rat cornea;Experimental Eye Research;2021-09

5. An ion‐paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection;Bioengineering & Translational Medicine;2021-06-22